Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vassallo

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Neurogastroenterology and Motility|June 21, 2016
Phenotyping of subjects for large scale studies on patients with IBSG E Boeckxstaens, V Drug, D Dumitrascu, et al.
European Journal of Anaesthesiology|May 30, 2020
A nebulised antitumour necrosis factor receptor-1 domain antibody in patients at risk of postoperative lung injury: A randomised, placebo-controlled pilot studyJames Ryan, Andrew I Bayliffe, Daniel F McAuley, et al.
Journal of Medicinal Chemistry|July 8, 1999
Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregationM S Egbertson, J J Cook, B Bednar, et al.
Environmental Research|December 3, 2020
Impact of the environment on the health: From theory to practiceA L Carducci, A Agodi, C Ancona, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Neurogastroenterology and Motility|June 21, 2016
Phenotyping of subjects for large scale studies on patients with IBSG E Boeckxstaens, V Drug, D Dumitrascu, et al.
European Journal of Anaesthesiology|May 30, 2020
A nebulised antitumour necrosis factor receptor-1 domain antibody in patients at risk of postoperative lung injury: A randomised, placebo-controlled pilot studyJames Ryan, Andrew I Bayliffe, Daniel F McAuley, et al.
Journal of Medicinal Chemistry|July 8, 1999
Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregationM S Egbertson, J J Cook, B Bednar, et al.
Environmental Research|December 3, 2020
Impact of the environment on the health: From theory to practiceA L Carducci, A Agodi, C Ancona, et al.
Pageof 10